Abstract.
DNA amplifications at 11q13 are frequently observed in esophageal squamous cell carcinoma (ESC) and correlate with a malignant phenotype. Although this amplicon spans a region of several megabases and harbors numerous genes, CCND1 and EMS1 are thought to be the relevant candidates in ESC. We investigated whether the putative transforming gene MYEOV, mapping 360 kb centromeric to CCND1 and activated concomitantly with CCND1 in a subset of t(11;14)(q13;q32) positive multiple myeloma cell lines, represents a target of 11q13 amplification in ESC. To evaluate the role of MYEOV in ESC, we tested 31 ESC cell lines and 48 primary tumors for copy number levels of MYEOV and demonstrated that MYEOV was always coamplified with CCND1. However, MYEOV expression levels correlated only inconsistently with DNA amplification data. Treatment with the demethylating agent 5-aza-2′-deoxycytidine restored MYEOV expression in a subset of cell lines exhibiting DNA amplification without high MYEOV expression, suggesting that MYEOV is transcriptionally silenced by a DNA methylation mechanism in most of the latter cell lines. Our results indicate that MYEOV is a coamplified gene with CCND1 at 11q13, but its activation is sometimes inhibited by an epigenetic mechanism.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: April 26, 2002 / Accepted: May 17, 2002
Rights and permissions
About this article
Cite this article
Janssen, J., Imoto, I., Inoue, J. et al. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. J Hum Genet 47, 460–464 (2002). https://doi.org/10.1007/s100380200065
Issue Date:
DOI: https://doi.org/10.1007/s100380200065
This article is cited by
-
MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway
BMC Cancer (2023)
-
MYEOV with High Frequencies of Mutations in Head and Neck Cancers Facilitates Cancer Cell Malignant Behaviors
Biochemical Genetics (2023)
-
Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes
World Journal of Surgical Oncology (2022)
-
MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity
Oncogene (2020)
-
MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV
Human Cell (2020)